AstraZeneca still blighted by long-term concerns, say analysts
01 May 2009
Sita Shah
Please Login to read the full article.
01 May 2009
Sita Shah
sita.shah@informa.com
AstraZeneca delivered strong margins in its first-quarter results this week, setting it in good stead for 2009, but long-term concerns still persist, analysts said.
The UK company posted 7% growth in sales at constant exchange rates (CER) to $7.7 billion (scripnews.com, April 30th, 2009)....
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
